image descriptionimage description

HUMIRA helps reduce pain and stop further joint damage in many adults1-2

If you are still experiencing moderate to severe rheumatoid arthritis symptoms like joint pain, stiffness, and swelling, ask your rheumatologist if HUMIRA can help

Many people treated for rheumatoid arthritis may still experience difficulty doing simple things like preparing a meal for your family or dressing themselves. HUMIRA may help reduce joint damage and reduce symptoms like joint pain, stiffness and swelling, and help you get back to carrying out your normal daily activities.

The government medicine funding agency, PHARMAC, fully subsidises HUMIRA if your rheumatoid arthritis has not fully responded to other medicines prescribed by a specialist, and you meet other criteria required by PHARMAC. Your specialist will discuss whether HUMIRA is right for you, and whether you may qualify for PHARMAC funded treatment.

Is it time to consider another rheumatoid arthritis treatment? Ask about HUMIRA

For some people with rheumatoid arthritis, treatment with conventional medicines such as:

  • analgesics
  • non-steroidal anti-inflammatory drugs (NSAIDs)
  • corticosteroids
  • disease-modifying anti-rheumatic drugs (DMARDs) such as methotrexate,

may not be enough to relieve rheumatoid arthritis symptoms.

HUMIRA is a biologic disease-modifying anti-rheumatic drug, also called a biologic DMARD, or simply “biologic”. HUMIRA works differently to conventional DMARDs because it works by identifying and blocking a specific source of inflammation that contributes to rheumatoid arthritis symptoms and it may be an option for you.

HUMIRA is only available on prescription, so if you are still experiencing symptoms of rheumatoid arthritis despite your current treatment, you should refer to your rheumatologist to see if HUMIRA is right for you.

HUMIRA helps reduce pain and stop further joint damage in many adults

Rheumatologists in New Zealand have been able to prescribe HUMIRA for over 10 years for rheumatoid arthritis, therefore it is a proven treatment option.

HUMIRA can be used alone, or in combination with other medicines.

HUMIRA can be used with methotrexate and clinical trials have shown that after 6 months at least twice as many people taking HUMIRA and methotrexate can expect to have a reduction in symptoms, than people on methotrexate alone. That’s why rheumatologists may prescribe HUMIRA for people who are already taking methotrexate but whose symptoms are not adequately controlled.

References
# All experiences, possible outcomes or improvements are hypothetical and based on significant clinical and Quality Of Life (QOL) improvements as measured in the listed clinical studies following HUMIRA treatment. Use of this statement does not imply endorsement or approval by any individual or the author.

  1. Weinblatt M E, et al. Arthritis Rheum 2003;48(1):35-45
  2. Keystone E C, et al. Arthritis Rheum 2004;50(5):1400-1411
  3. van Vollenhoven R. et al. Arthritis Care & Research. 2010; 62:2:226-34
NZ-HUM-0114 TAPS PP9594 Prepared May 2017

Learn how HUMIRA works

Watch this short video to get a better understanding of how HUMIRA targets and helps to block TNF.

How HUMIRA treatment works video transcript

Usually, your immune system defends your body from many of the things that can harm it. But when the system doesn’t work right, it can attack healthy tissues and organs. This is an autoimmune disease. One part of your immune system is a protein called TNF, which is produced naturally by the body’s immune system. But in certain autoimmune diseases, some people produce too much TNF. This often leads to inflammation. HUMIRA is a medication called a TNF blocker. It works by binding to TNF molecules and blocking them from attaching to and making cells behave in a way which leads to effects on health. In this way, HUMIRA helps reduce the damaging effects of excess TNF. Remember, although HUMIRA can’t stop your body’s overproduction of TNF it can reduce its effects.

The immune system can overproduce the TNF protein, which is one source of inflammation that contributes to the symptoms of rheumatoid arthritis. HUMIRA targets and helps block TNF (a particular protein), reducing its inflammatory effects on the joints and the symptoms of joint pain, swelling, and stiffness.

Talk to your rheumatologist about whether HUMIRA is right for treating your rheumatoid arthritis

# All experiences, possible outcomes or improvements are hypothetical and based on significant clinical and Quality Of Life (QOL) improvements as measured in the listed clinical studies following HUMIRA treatment. Use of this statement does not imply endorsement or approval by any individual or the author.
1. van Vollenhoven R. et al. Arthritis Care & Research. 2010; 62:2:226-34
2. Keystone E. et al. Arth & Rheum. 2004 ;50: 1400 – 11

NZ-HUM-0114 TAPS PP9594 Prepared May 2017

Getting results with HUMIRA for rheumatoid arthritis

In clinical studies, some people on HUMIRA and methotrexate have seen improvement in their rheumatoid arthritis symptoms in as little as two weeks. For others, it may take up to three months or longer to possibly notice less pain, swelling, and joint stiffness.1-2

Start out on the right path by learning how to take HUMIRA correctly

The usual recommended dose for adults with rheumatoid arthritis is a 40mg injection once every two weeks. Your rheumatologist will decide what dosage of HUMIRA you require and how often you need to administer the injection. Only inject as prescribed by them.

HUMIRA is given by injection just under the skin. HUMIRA is available in either a pre-filled single use syringe, or pre-filled single-use auto-injector pen and both come pre-loaded with the exact dose of medicine inside, so it comes ready to inject and you can do it by yourself. Your rheumatologist or nurse will be able to help you and be with you for your first injection however before long you will be able to do it by yourself, or if not, it can be given by another healthcare professional or a family member or friend after they have been trained to give injections. Also, for people on HUMIRA in New Zealand you can join the AbbVie Care support programme for added support, see below.

Watch these short videos to get a better understanding of how to inject HUMIRA.

Pen video also available in the following languages:
Hindi    Simplified Chinese    Samoan    Tongan

NZ-IMM-0046

Syringe video also available in the following languages:
Hindi    Simplified Chinese    Samoan    Tongan

NZ-IMM-0047

Storage and travelling with HUMIRA

Keep HUMIRA in the outer carton until it is time to use it. HUMIRA must be kept in the refrigerator (+2° C to +8° C) but don’t allow it to freeze. If you are travelling the HUMIRA pre-filled pen or pre-filled syringe may be stored at room temperature (below +25° C) for a maximum period of 14 days, but it must be protected from light. Once removed from the refrigerator for room temperature storage, the syringe or pen must be used within 14 days or discarded even if it is returned to the refrigerator. If additional syringes or pens are being carried, they should be refrigerated (kept between 2°C–8°C).

Join AbbVie Care to receive an ice pack and order a travel wallet through www.abbviecare.co.nz or call 0800 848 243.

When planning to travel overseas it is important that you:

  • talk to your doctor about travelling with HUMIRA
  • carry a letter from your doctor detailing what HUMIRA is, how much you will be taking, and stating that it is for your own personal use
  • leave HUMIRA in its original packaging so it is clearly labeled with your name and dosage instructions (if you are taking HUMIRA pens/syringes with you)


AbbVie Care Support Programme helps take care of you

AbbVie Care is available to you when you are taking HUMIRA. Support from AbbVie Care is designed to complement the care you receive from your specialist and clinic nurse.
AbbVie Care provides personalised support to meet each person’s needs. The aim is by working together people can achieve better outcomes with their health and quality of life.

It’s easy to ENROL

JOIN AbbVie Care to get the best out of your HUMIRA treatment
• Go online to www.abbviecare.co.nz
• Call 0800 848 243

How AbbVie Care supports you:

AbbVie Care Nurse

AbbVie Care Nurse Support

– Home visits or phone calls to help with injecting^
– Scheduled phone calls to provide information and support
– An 0800 number to call when you have a question

www.abbviecare.co.nz

www.AbbVieCare.co.nz

– Helpful resources and tools (ie. travel advice)
– The ability to order your sharps container and travel wallet online
– Medication and appointment reminders
– Visit www.abbviecare.co.nz

AbbvieCare_online-com

Online Community

– Connecting you to others on HUMIRA
– Contact with your AbbVie Care Nurse

AbbvieCare Sharps Disposal Programme

Sharps Disposal Programme

– Delivery of sharps container to safely dispose of your HUMIRA pens and syringes
– Access to pharmacy disposal of your sharps container

AbbvieCare Travel Wallet

Travel Wallet

– Designed to make travelling with HUMIRA safer and easier

Abbvie_Care_Welcome_Kit

Welcome Kit

– Information on all you need to know to get the best out of AbbVie Care
– Ice pack to assist with injecting


References:
All experiences, possible outcomes or improvements are hypothetical and based on significant Quality Of Life (QOL) improvements as measured in the listed clinical studies. Use of these references does not imply endorsement or approval by any individual or the authors.
^Home visits do not cover all of New Zealand. Your AbbVie Care Nurse will be able to discuss this with you when you join AbbVie Care.

  1. Weinblatt M E, et al. Arthritis Rheum 2003;48(1):35-45
  2. Keystone E C, et al. Arthritis Rheum 2004;50(5):1400-1411
  3. van Vollenhoven R. et al. Arthritis Care & Research. 2010; 62:2:226-34
NZ-HUM-0114 TAPS PP9594 Prepared May 2017

RESOURCES

The following resources have been compiled to help you get support outside the HUMIRA AbbVie Care programme. We hope you find them useful.

Arthritis New Zealandlogo_Arthritis-New-Zealand

A national voluntary organisation which represents the interests of those with arthritis. Information on the condition and its treatment.
www.arthritis.org.nz

Arthritis Australia

An Australian national organisation which represents the interests of those with arthritis. Information on the condition and its treatment.
www.arthritisaustralia.com.au

Arthritis UK

The United Kingdom’s national organisation which represents the interests of those with arthritis. Information on the condition and its treatment.
www.arthritiscare.org.uk

New Zealand Rheumatology Association

The New Zealand Rheumatology Association (NZRA) is the organisation that represents the rheumatologists of New Zealand.
www.rheumatology.org.nz

Use this link to search for Rheumatologists. You can type in a city, region or surname.

Australian Rheumatology Association

The ARA is an association of rheumatologists in Australia that is a specialty society of the Royal Australasian College of Physicians (RACP).
www.rheumatology.org.au

Information sheets are available via the Arthritis Australia website at the following link.

Arthritis Foundation USA

An American national organisation which represents the interests of those with arthritis. Information on the condition and its treatment.
www.arthritis.org

American College of Rheumatology

The American College of Rheumatology (ACR) is an ethically-driven, professional membership organization committed to improving the care of patients with rheumatic disease and advancing the rheumatology subspecialty.
www.rheumatology.org

Health Navigator New Zealand

The Health Navigator website provides one place for New Zealanders to find reliable and trustworthy health information and self-care resources. It focuses on promoting clear, consistent messages that enable users to get the information they need at the time they need it.
www.healthnavigator.org.nz/

# All experiences, possible outcomes or improvements are hypothetical and based on significant clinical and Quality Of Life (QOL) improvements as measured in the listed clinical studies following HUMIRA treatment. Use of this statement does not imply endorsement or approval by any individual or the author.
1. van Vollenhoven R. et al. Arthritis Care & Research. 2010; 62:2:226-34
2. Keystone E. et al. Arth & Rheum. 2004 ;50: 1400 – 11

NZ-HUM-0114 TAPS PP9594  Prepared May 2017